Agilent Technologies, Inc. (NYSE:A) Shares Acquired by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 11.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 184,715 shares of the medical research company’s stock after buying an additional 18,474 shares during the quarter. PNC Financial Services Group Inc. owned about 0.06% of Agilent Technologies worth $24,815,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in A. Massachusetts Financial Services Co. MA grew its position in shares of Agilent Technologies by 3.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock worth $2,314,784,000 after acquiring an additional 525,214 shares during the last quarter. FMR LLC boosted its stake in Agilent Technologies by 62.2% during the 3rd quarter. FMR LLC now owns 1,287,665 shares of the medical research company’s stock valued at $191,193,000 after purchasing an additional 493,947 shares during the period. Raymond James Financial Inc. bought a new position in Agilent Technologies in the 4th quarter worth about $48,172,000. Worldquant Millennium Advisors LLC acquired a new stake in shares of Agilent Technologies in the third quarter valued at approximately $49,449,000. Finally, Van ECK Associates Corp raised its holdings in shares of Agilent Technologies by 8.7% during the fourth quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company’s stock valued at $434,625,000 after buying an additional 258,358 shares during the last quarter. 87.42% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.26% of the company’s stock.

Wall Street Analysts Forecast Growth

A has been the subject of a number of recent analyst reports. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. JPMorgan Chase & Co. decreased their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. Bank of America lowered their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Robert W. Baird reduced their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a report on Thursday, February 27th. Finally, Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $146.15.

Agilent Technologies Trading Down 3.7 %

Shares of NYSE:A opened at $122.02 on Tuesday. The stock has a market capitalization of $34.79 billion, a price-to-earnings ratio of 28.05, a PEG ratio of 3.56 and a beta of 1.11. Agilent Technologies, Inc. has a 1-year low of $121.45 and a 1-year high of $155.35. The company has a 50 day moving average price of $139.42 and a 200 day moving average price of $138.55. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, research analysts anticipate that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.81%. Agilent Technologies’s payout ratio is presently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.